https://app.claidex.com 2026-06-10T16:50:13.612Z daily 1 https://app.claidex.com/claims 2026-06-10T16:50:13.612Z daily 1 https://app.claidex.com/preprint 2026-06-10T16:50:13.612Z daily 0.9 https://app.claidex.com/dashboard/api 2026-06-10T16:50:13.612Z weekly 0.8 https://app.claidex.com/mcp 2026-06-10T16:50:13.612Z weekly 0.8 https://app.claidex.com/claims/soticlestat-cyp46a1-dravet-lennox-gastaut-phase3-efficacy-failure 2026-06-09T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/vodobatinib-abl1-dementia-with-lewy-bodies-phase2-translational-mismatch 2026-06-09T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/pf-07265807-mertk-axl-solid-tumors-phase1-strategic-reprioritization 2026-06-07T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/lenvatinib-pembrolizumab-kdr-melanoma-brain-metastases-phase2-efficacy-failure 2026-06-07T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/alpelisib-olaparib-pik3ca-ovarian-epik-o-phase3-efficacy-failure 2026-06-06T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/incb099280-cd274-oral-pd-l1-solid-tumors-phase1-strategic-discontinuation 2026-06-06T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/venetoclax-azacitidine-bcl2-aml-post-transplant-maintenance-phase3-strategic-termination 2026-06-05T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/jnj-95475939-il31-atopic-dermatitis-phase2b-duplex-ad-futility 2026-06-05T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/eciskafusp-alfa-pd1-il2v-il2rb-solid-tumors-phase1-orr-futility 2026-06-03T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/linaprazan-glurate-atp4a-pcab-gerd-phase3-strategic-withdrawal 2026-06-03T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/gsk1070806-il18-atopic-dermatitis-phase2b-efficacy-futility 2026-06-03T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/bgb-53038-kras-solid-tumors-phase1-strategic-reprioritization 2026-06-03T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/deucravacitinib-tyk2-hidradenitis-suppurativa-phase2-funding-withdrawal 2026-06-03T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/delocamten-myk224-myh7-ohcm-mercutio-business-termination 2026-06-02T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/inhaled-treprostinil-ptgir-ph-copd-perfect-extension-termination 2026-06-02T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/pro1107-ptk7-solid-tumors-phase1-2-benefit-risk-discontinuation 2026-06-02T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/nogapendekin-alfa-inbakicept-il15-nsclc-quilt-2023-phase3-reprioritization 2026-06-02T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/ono-7018-malt1-nhl-cll-phase1-strategic-discontinuation 2026-06-01T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/gs-0272-btla-rheumatoid-arthritis-phase1b-efficacy-termination 2026-06-01T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/certepetide-nrp1-cholangiocarcinoma-bolster-phase2-termination 2026-05-31T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/bgb-45035-irak4-rheumatoid-arthritis-phase2-efficacy-termination 2026-05-31T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/crd-4730-camk2d-cpvt1-phase2-sponsor-termination 2026-05-31T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/bemcentinib-axl-lung-adenocarcinoma-phase1b2-supply-termination 2026-05-31T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/govorestat-akr1b1-cmt-sord-phase3-withdrawal 2026-05-30T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/nbi-921352-scn8a-dee13-sponsor-shutdown 2026-05-30T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/olutasidenib-idh1-cmml-mds-mpn-mdacc-pi-withdrawal 2026-05-25T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/abemaciclib-cdk46-hnscc-window-aim-soc-shift 2026-05-25T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/aro-ang3-zodasiran-hofh-phase2-strategic-shutdown 2026-05-24T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/amag-423-digoxin-immune-fab-severe-preeclampsia-dsmb-futility 2026-05-24T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/azenosertib-wee1-zap-it-tnbc-safety-termination 2026-05-23T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/mt-1186-oral-edaravone-sod1-als-phase3-futility 2026-05-23T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/bg-60366-egfr-cdac-nsclc-strategic-shutdown 2026-05-22T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/opc-167832-dbos-pbos-tb-3-month-regimen-efficacy-failure 2026-05-22T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/ds2325a-klk5-netherton-syndrome-business-decision 2026-05-21T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/lerociclib-cdk46-eqrx-shutdown-hr-breast-cancer 2026-05-21T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/tol-3021-proinsulin-dna-vaccine-t1d-dsmb-futility 2026-05-20T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/daxdilimab-lilra4-discoid-lupus-sponsor-shutdown 2026-05-20T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/gen3014-hexabody-cd38-rrmm-portfolio-shutdown 2026-05-20T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/inb03-soluble-tnf-covid19-ards-futility 2026-05-20T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/mij821-onfasprodil-mdd-suicidality-efficacy-failure 2026-05-19T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/ociperlimab-tigit-advantig-302-nsclc-class-failure 2026-05-19T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/icovamenib-t1d-covalent-112-portfolio-shutdown 2026-05-19T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/lithium-unc13a-magnet-als-biomarker-failure 2026-05-19T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/tusamitamab-ravtansine-ceacam5-adc-phase3 2026-05-18T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/bg-89894-mat2a-mtap-portfolio-shutdown 2026-05-18T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/revision-tenecteplase-crao-futility 2026-05-18T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/imsa101-sting-agonist-immunesensor-shutdown 2026-05-18T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/exicorilant-mcrpc-gr-bypass-fourth-failure 2026-05-17T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/alpelisib-epik-b3-tnbc 2026-05-17T00:00:00.000Z monthly 0.9 https://app.claidex.com/claims/brigimadlin-mdm2-class-shutdown 2026-05-17T00:00:00.000Z monthly 0.9 https://app.claidex.com/preprint/2026-06-09_preprint-watch-16 2026-06-09T00:00:00.000Z weekly 0.7 https://app.claidex.com/preprint/2026-06-07_preprint-watch-14 2026-06-07T00:00:00.000Z weekly 0.7 https://app.claidex.com/preprint/2026-06-07_preprint-watch-15 2026-06-07T00:00:00.000Z weekly 0.7 https://app.claidex.com/preprint/2026-06-06_preprint-watch-13 2026-06-06T00:00:00.000Z weekly 0.7 https://app.claidex.com/preprint/2026-06-05_preprint-watch-12 2026-06-05T00:00:00.000Z weekly 0.7 https://app.claidex.com/preprint/2026-06-03_preprint-watch-10 2026-06-03T00:00:00.000Z weekly 0.7 https://app.claidex.com/preprint/2026-06-03_preprint-watch-11 2026-06-03T00:00:00.000Z weekly 0.7 https://app.claidex.com/preprint/2026-06-02_preprint-watch-9 2026-06-02T00:00:00.000Z weekly 0.7 https://app.claidex.com/preprint/2026-05-25_preprint-watch-8 2026-05-25T00:00:00.000Z weekly 0.7 https://app.claidex.com/preprint/2026-05-24_preprint-watch-6 2026-05-24T00:00:00.000Z weekly 0.7 https://app.claidex.com/preprint/2026-05-24_preprint-watch-7 2026-05-24T00:00:00.000Z weekly 0.7 https://app.claidex.com/preprint/2026-05-22_preprint-watch-4 2026-05-22T00:00:00.000Z weekly 0.7 https://app.claidex.com/preprint/2026-05-22_preprint-watch-5 2026-05-22T00:00:00.000Z weekly 0.7 https://app.claidex.com/preprint/2026-05-21_preprint-watch-1 2026-05-21T00:00:00.000Z weekly 0.7 https://app.claidex.com/preprint/2026-05-20_preprint-watch-2 2026-05-20T00:00:00.000Z weekly 0.7 https://app.claidex.com/preprint/2026-05-20_preprint-watch-3 2026-05-20T00:00:00.000Z weekly 0.7